Related Experiment Video

Updated: Sep 8, 2025

Preparation of Myeloid Derived Suppressor Cells MDSC from Naive and Pancreatic Tumor-bearing Mice using Flow Cytometry and Automated Magnetic Activated Cell Sorting AutoMACS
14:15

Preparation of Myeloid Derived Suppressor Cells MDSC from Naive and Pancreatic Tumor-bearing Mice using Flow Cytometry and Automated Magnetic Activated Cell Sorting AutoMACS

Published on: June 18, 2012

26.3K

Myeloid-derived suppressor cells in cancer

Jun Gao1,2, Wei-Ren Liu1,2, Zheng Tang1,2

  • 1Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China.

Iliver
|July 10, 2025
PubMed

Insights

Myeloid-derived suppressor cells (MDSCs) are key in cancer, with gene therapies offering innovative ways to target them. Understanding MDSC phenotypes and functions is crucial for modifying the tumor microenvironment and developing new cancer treatments.

Area of Science:

  • Immunology
  • Oncology
  • Cell Biology

Background:

  • Myeloid-derived suppressor cells (MDSCs) are a heterogeneous population of immunosuppressive cells.
  • MDSC dysregulation is observed in numerous cancer types.
  • MDSCs significantly influence the tumor microenvironment through various phenotypes and functions.

Purpose of the Study:

  • To summarize current research on MDSC phenotypes, functions, and mechanisms.
  • To explore the therapeutic potential of targeting MDSCs in cancer.
  • To investigate the role of chemokines in modulating MDSC subpopulations.

Main Methods:

  • Literature review of recent studies on MDSCs in cancer.
  • Analysis of MDSC phenotypes and their impact on the tumor microenvironment.
  • Exploration of gene therapy strategies for MDSC modification.

Main Results:

  • MDSCs exhibit diverse phenotypes and play critical roles in cancer progression.
  • Gene therapies present innovative and flexible approaches to target MDSCs.
  • Chemokines are identified as key regulators of MDSC subpopulation balance.

Conclusions:

  • Targeting MDSCs holds significant therapeutic promise for cancer treatment.
  • Further research into MDSC mechanisms and chemokine regulation can optimize immunotherapies.
  • Understanding MDSC heterogeneity is essential for developing effective cancer therapies.
Keywords:
ImmunostimulatoryImmunosuppressionMyeloid-derived suppressor cellsTargeted therapyTumor microenvironment

More Related Videos

Isolation and Characterization of Neutrophils with Anti-Tumor Properties10:15

Isolation and Characterization of Neutrophils with Anti-Tumor Properties

Published on: June 19, 2015

25.0K
Functional Characterization of Regulatory Macrophages That Inhibit Graft-reactive Immunity08:41

Functional Characterization of Regulatory Macrophages That Inhibit Graft-reactive Immunity

Published on: June 7, 2017

8.3K

Related Concept Videos

Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.3K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.9K
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.0K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K